Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
Authors
Keywords
-
Journal
Viruses-Basel
Volume 13, Issue 8, Pages 1656
Publisher
MDPI AG
Online
2021-08-23
DOI
10.3390/v13081656
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
- (2021) Susan M. Burks et al. BRAIN BEHAVIOR AND IMMUNITY
- Neuroinvasion of SARS-CoV-2 in human and mouse brain
- (2021) Eric Song et al. JOURNAL OF EXPERIMENTAL MEDICINE
- 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
- (2021) Chaolin Huang et al. LANCET
- SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients
- (2021) Marton Olbei et al. Frontiers in Immunology
- Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
- (2021) Jeremy R.A. Paull et al. ANTIVIRAL RESEARCH
- Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2
- (2020) Ren-Di Jiang et al. CELL
- SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
- (2020) Yijin Wang et al. JOURNAL OF HEPATOLOGY
- Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals
- (2020) Yuan Liu et al. NATURE
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
- (2020) Linlin Bao et al. NATURE
- SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes
- (2020) Waradon Sungnak et al. NATURE MEDICINE
- Liver injury in COVID-19: management and challenges
- (2020) Chao Zhang et al. Lancet Gastroenterology & Hepatology
- Aerosol Transmission of SARS-CoV-2? Evidence, Prevention and Control
- (2020) Song Tang et al. ENVIRONMENT INTERNATIONAL
- Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment
- (2020) G. Buonanno et al. ENVIRONMENT INTERNATIONAL
- Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
- (2020) Sonu Bhaskar et al. Frontiers in Immunology
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19
- (2020) Marthe Jøntvedt Jørgensen et al. Scientific Reports
- Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004)
- (2011) Ian McGowan et al. AIDS
- Virucidal activity of the dendrimer microbicide SPL7013 against HIV-1
- (2011) Sushama Telwatte et al. ANTIVIRAL RESEARCH
- Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity
- (2010) David Tyssen et al. PLoS One
- Safety, Tolerability, and Pharmacokinetics of SPL7013 Gel (VivaGel®): A Dose Ranging, Phase I Study
- (2010) John OʼLoughlin et al. SEXUALLY TRANSMITTED DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now